XNASHSCS
Market cap3mUSD
Dec 24, Last price
3.69USD
1D
-0.32%
1Q
-15.60%
IPO
52.40%
Name
Heart Test Laboratories Inc
Chart & Performance
P/E
—
P/S
194.38
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
19k
+261.17%
Net income
-7m
L-98.65%
CFO
-6m
L+5.14%
Profile
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑04 | 2023‑04 | 2022‑04 | 2021‑04 | 2020‑04 | |
| Income | |||||
Revenues | 19 261.17% | 5 -64.17% | 14 -43.86% | ||
Cost of revenue | 2,885 | 2,464 | 3,009 | ||
Unusual Expense (Income) | |||||
NOPBT | (2,866) | (2,459) | (2,995) | ||
NOPBT Margin | |||||
Operating Taxes | 484,500 | (250) | |||
Tax Rate | |||||
NOPAT | (2,866) | (486,959) | (2,745) | ||
Net income | (6,605) -98.65% | (490,854) 10,621.88% | (4,578) 77.36% | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | 10,300 | 5,624 | 555,767 | ||
BB yield | -31,621.47% | -7,970.54% | |||
| Debt | |||||
Debt current | 602 | 530 | 1,721 | ||
Long-term debt | 970 | 1,602 | 4,533 | ||
Deferred revenue | |||||
Other long-term liabilities | 187 | 233 | |||
Net debt | (4,235) | 471 | 5,335 | ||
| Cash flow | |||||
Cash from operating activities | (6,070) | (5,774) | (3,644) | ||
CAPEX | (64) | (18) | (2) | ||
Cash from investing activities | (125) | (18) | (2) | ||
Cash from financing activities | 10,343 | 6,534 | 3,841 | ||
FCF | (3,232) | (487,505) | (2,343) | ||
| Balance | |||||
Cash | 5,808 | 1,660 | 918 | ||
Long term investments | |||||
Excess cash | 5,807 | 1,660 | 918 | ||
Stockholders' equity | (67,361) | (61,128) | (54,399) | ||
Invested Capital | 75,715 | 62,488 | 54,739 | ||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | 353 | 80 | 33 | ||
Price | 0.09 -89.59% | 0.89 | |||
Market cap | 33 -53.84% | 71 | |||
EV | (4,202) | 542 | |||
EBITDA | (2,771) | (2,432) | (2,968) | ||
EV/EBITDA | 1.52 | ||||
Interest | 354 | 243 | 372 | ||
Interest/NOPBT | |||||